Registry for people with ME/CFS
Part of Bones, joints & muscles, Brain & nervous system, Infections clinical trials.
This study is a registry, meaning it collects information from people who have ME/CFS. It helps researchers better understand ME/CFS and may guide future studies that could improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of ME/CFS (chronic fatigue syndrome) based on accepted medical criteria
- You can (or your guardian can) agree to participate by signing the consent form
- You must have ME/CFS—this study is not for other conditions
- You must be willing to participate and provide required study information
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study observes how a blood-cleaning treatment called immunoadsorption works in patients with ME/CFS (severe fatigue condition) who have specific immune markers. Researchers will track whether this treatment helps reduce symptoms and improve daily functioning.
This study is testing a way to improve medical care for people with ME/CFS (including post-COVID ME/CFS) who are mostly homebound. The goal is to see if bringing healthcare to your home helps you better manage your condition.
This study is tracking children, teens, and young adults (up to age 25) who developed ME/CFS after an infection. It aims to better understand the condition in younger people.
This study builds a health registry to learn how long COVID affects children, teens, and adults over time. It may help by improving understanding of symptoms and care, even if it does not test a new drug.
This study looks at how chronic infections and inflammation affect people with ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) compared to healthy people. Researchers want to understand what causes symptoms and find better ways to help.
This study looks at how the brain's protective barrier and immune system work in people with ME/CFS, comparing those who got sick before the COVID-19 pandemic to those who developed ME/CFS after a COVID-19 infection. It aims to understand why some people have lasting brain fog, fatigue, and other neuropsychiatric symptoms.
Hear when a new ME/CFS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.